Skip to main content
logo
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
20.29
+0.70 (3.57%)
At close: Apr 14, 2026, 4:00 PM EDT
20.61
+0.32 (1.55%)
After-hours: Apr 14, 2026, 6:50 PM EDT

KalVista Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023
Period Ending
Apr '26 Apr '25 Apr '24
Market Cap
1,039685483
Market Cap Growth
69.41%41.98%-
Enterprise Value
1,023574.82278.24
Last Close Price
20.2913.7711.35
PE Ratio
--3.73-3.30
PB Ratio
-7.182.34
P/TBV Ratio
60.337.172.02
P/FCF Ratio
--4.47-5.41
P/OCF Ratio
--4.48-5.41
EV/EBITDA Ratio
--3.07-1.99
EV/EBIT Ratio
--3.06-1.98
EV/FCF Ratio
--3.75-3.12
Debt / Equity Ratio
16.351.160.03
Debt / EBITDA Ratio
--0.60-0.05
Debt / FCF Ratio
--0.73-0.08
Net Debt / Equity Ratio
-1.56-1.14-0.98
Net Debt / EBITDA Ratio
-0.581.45
Net Debt / FCF Ratio
-0.712.28
Quick Ratio
7.024.929.60
Current Ratio
7.225.359.90
Return on Equity (ROE)
--121.50%-61.30%
Return on Assets (ROA)
--78.79%-59.66%
Return on Invested Capital (ROIC)
--26219.90%-4015.01%
Return on Capital Employed (ROCE)
--89.91%-66.06%
Earnings Yield
-15.81%-26.80%-30.31%
FCF Yield
-12.03%-22.38%-18.50%
Buyback Yield / Dilution
-12.32%-34.98%-
Total Shareholder Return
-12.32%-34.98%-
Updated Nov 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q